Agricommodity TipsBest Stock Advisory Companybest stock advisory company in indoreBest Stock Advisory Company in Indore|stock market advisory tips|Top 10 advisory in Indore|HNI Commodity Pack
Alembic Pharmaceuticals rises 3% on EIR for Karakhadi unit from USFDA
USFDA had carried out an inspection at Alero's formulation facility at Karakhadi, Gujarat, India during the period from February 4 to 8, 2019.
Pharmaceuticals rose more than 3 percent intraday Monday after the company received establishment inspection report (EIR) from USFDA.
Aleor Dermaceuticals, a 60:40 joint venture between Alembic Pharmaceuticals and Orbicular Pharmaceutical Technologies, has received establishment inspection report (EIR) from the United States Food and Drug Administration (USFDA).
USFDA had carried out an inspection at Alero's formulation facility at Karakhadi, Gujarat, India during the period from February 4 to 8, 2019.
At 11:13 hrs Alembic Pharmaceuticals was quoting at Rs 548.40, up to Rs 6.00, or 1.11 percent on the BSE.
The share touched its 52-week high Rs 664 and 52-week low Rs 412.40 on 27 September 2018 and 24 May 2018, respectively.
Currently, it is trading 17.41 percent below its 52-week high and 32.98 percent above its 52-week low.
Get MCX Tips to start from 2 Days Free Trial Click Here- MCX Tips “We Provide Secure, and Smooth Deals You Can Trust”
0 comments
Note: only a member of this blog may post a comment.